Boost Your Post-Marketing Efforts with Our Phase IV Clinical Trials

If your compound has reached a Phase IV study, it means that you have been fortunate enough to experience clinical study success. This phase focuses primarily on monitoring side effects and building a safety database, with an eye toward potential future work with the drug. With efficacy no longer the primary concern, developing the ability to support marketing of the product through additional safety data comes to the forefront. While Phase IV clinical trials are widely considered the easiest of the study phases, that certainly makes them no less important.

Here at Datatrial, we use our nowEDC™ software to give you real-time access to your data, reducing the need for frequent site visits—which makes your study budget to go further. Our EDC system not only bypasses the cumbersome process of collecting and distributing paper forms in your Phase IV study, but also allows for the incorporation of different patient cycles and helps you more easily manage a small number of patients at a high number of sites.

Take Advantage of Our Unique Approach to Phase IV Clinical Trials

Our stress free study delivery experts are eager to help develop your compound with assistance at every step along the way. We also have extensive experience in early-phase and Phase III.

Please contact us to find out more about how we can handle your Phase IV study.